Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Prediction Markets
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $17 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
HC Wainwright & Co. analyst Patrick Trucchio reiterates Precision BioSciences (NASDAQ:DTIL) with a Buy and maintains $17 price target.

DTIL

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Needham Reiterates Buy on SentinelOne, Maintains $19 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
Needham analyst Alex Henderson reiterates SentinelOne (NYSE:S) with a Buy and maintains $19 price target.

S

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

HC Wainwright & Co. Reiterates Buy on Tarsus Pharmaceuticals, Maintains $40 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
HC Wainwright & Co. analyst Oren Livnat reiterates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and maintains $40 price target.

TARS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Needham Reiterates Buy on Super Group (SGHC), Maintains $5 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
Needham analyst Bernie McTernan reiterates Super Group (SGHC) (NYSE:SGHC) with a Buy and maintains $5 price target.

SGHC

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Telsey Advisory Group Reiterates Outperform on Grove Collaborative Hldgs, Maintains $3 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
Telsey Advisory Group analyst Dana Telsey reiterates Grove Collaborative Hldgs (NYSE:GROV) with a Outperform and maintains $3 price target.

GROV

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Telsey Advisory Group Reiterates Outperform on Westrock Coffee, Maintains $15 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
Telsey Advisory Group analyst Sarang Vora reiterates Westrock Coffee (NASDAQ:WEST) with a Outperform and maintains $15 price target.

WEST

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Telsey Advisory Group Reiterates Market Perform on Guess, Maintains $23 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
Telsey Advisory Group analyst Dana Telsey reiterates Guess (NYSE:GES) with a Market Perform and maintains $23 price target.

GES

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

EF Hutton Reiterates Buy on Agenus, Maintains $8.3 Price Target

By Benzinga Newsdesk
Today, 9:49 PM
EF Hutton analyst Michael King reiterates Agenus (NASDAQ:AGEN) with a Buy and maintains $8.3 price target.

AGEN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Penny Stocks
  • Price Target
  • Reiteration

TrueCar’s Analyst Highlights New Vehicle Sales, Migration To Subscription Model As Growth Catalysts, Upgrades Stock

By Anusuya Lahiri
Today, 9:49 PM
Needham analyst Chris Pierce upgrades TrueCar Inc (NASDAQ:TRUE) from Hold to Buy and a $3.5 price target. Historically, TrueCar was ~2/3rds levered…

AN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Price Target
  • Reiteration

Hyatt Hotels To See 25% FCF/Share Growth Through 2025: Analyst

By Shivani Kumaresan
Today, 9:49 PM
Morgan Stanley analyst Stephen W Grambling reiterated an Overweight rating (Top Pick) on the shares of Hyatt Hotels Corporation (NYSE:H) with…

H

Posts navigation

Previous 1 … 3 4 5 … 272 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service